Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on a Functional Respiratory Imaging (FRI) Model

M. Nagel (London (ON), Canada), A. Bracey (Hampshire, United Kingdom), A. Ellery (London (ON), Canada), J. Suggett (London (ON), Canada)

Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Nagel (London (ON), Canada), A. Bracey (Hampshire, United Kingdom), A. Ellery (London (ON), Canada), J. Suggett (London (ON), Canada). Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on a Functional Respiratory Imaging (FRI) Model. 4281

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on an In-Vitro Drug Delivery Model
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Pressurized Metered Dose Inhaler (pMDI) Delivery to Infants via Valved Holding Chamber (VHC) with Facemask: Not All VHCs Perform the Same
Source: International Congress 2017 – Inhalers and their use
Year: 2017

Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI).
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019

Combining Inhalation by A Breath Actuated Nebuliser (BAN) With Exhalation Through An Oscillating Positive Expiratory Pressure Device (OPEP) Offers The Potential For Optimal Combined Therapy
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Time is Essential for Competant Inhaler Technique Training
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019


Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


BREEZE: Open-label, Clinical Study to Evaluate the Safety and Tolerability of a Treprostinil Dry Powder Inhaler in Patients with Pulmonary Arterial Hypertension Currently Using Tyvaso
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


The Effectiveness of Disinfecting Wipes on the Mechanical Ventilator Surfaces: A Pilot Study
Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Year: 2020


Compared Aerosol Drug Delivery Efficacy of Two Types Nebulizer in Adult Mechanical Ventilator
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017


Delivery of Respimat Soft Mist inhaler (SMI) from a Valved Holding Chamber (VHC)
Source: International Congress 2017 – Inhalers and their use
Year: 2017

Efficiency of a Nebulizer Filter Kit to Prevent Environmental Contamination During Nebulizer Therapy
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


Life Cycle Assessment (LCA) and Cradle-to-Grave (CTG) Carbon Footprint of a Multidose Reservoir Dry Powder Inhaler
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Pressurized Metered Dose Inhaler (pMDI) - Correct procedure
Source: Procedure Video 2018
Year: 2018

COPD Subject’s Degree of Therapy Comfort in an Oscillating Next Generation Noninvasive Ventilator
Source: International Congress 2019 – New strategies to treat respiratory failure
Year: 2019


Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019



Pressurized Metered Dose Inhaler (pMDI) with holding chamber - Correct procedure
Source: Procedure Video 2018
Year: 2018

Dry Powder Inhaler - Correct procedure
Source: Procedure Video 2018
Year: 2018

Late Breaking Abstract - Comparison of Portable Oxygen Concentrators using a COPD Patient Simulation Model
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021


Safety, Tolerability (S&T) and Pharmacokinetics (PK) of Single and Repeat Inhaled Doses of Phosphoinositide-3-Kinase Delta Inhibitor (PI3Kd) GSK2269557, Delivered via the ELLIPTATM Device to Healthy Subjects in a Phase I Trial, Including Charcoal Block.
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017